Cited by 77Dermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisAdvancements in Transdermal Drug Delivery

Epidermal Inactivation of the Glucocorticoid Receptor Triggers Skin Barrier Defects and Cutaneous Inflammation

Open access
Sevilla, Lisa M., Latorre, Víctor, Sanchis, Ana, Pérez, Paloma·2013·Journal of Investigative Dermatology

Abstract

The glucocorticoid (GC) receptor (GR) mediates the effects of physiological and pharmacological GC ligands and has a major role in cutaneous pathophysiology. To dissect the epithelial versus mesenchymal contribution of GR in developing and adult skin, we generated mice with keratinocyte-restricted GR inactivation (GR epidermal knockout or GR(EKO) mice). Developing and early postnatal GR(EKO) mice exhibited impaired epidermal barrier formation, abnormal keratinocyte differentiation, hyperproliferation, and stratum corneum (SC) fragility. At birth, GR(EKO) epidermis showed altered levels of epidermal differentiation complex genes, proteases and protease inhibitors which participate in SC maintenance, and innate immunity genes. Many upregulated genes, including S100a8/a9 and Tslp, also have increased expression in inflammatory skin diseases. Infiltration of macrophages and degranulating mast cells were observed in newborn GR(EKO) skin, hallmarks of atopic dermatitis. In addition to increased extracellular signal-regulated kinase activation, GR(EKO) newborn and adult epidermis had increased levels of phosphorylated signal transducer and activator of transcription 3, a feature of psoriasis. Although adult GR(EKO) epidermis had a mild phenotype of increased proliferation, perturbation of skin homeostasis with detergent or phorbol ester triggered an exaggerated proliferative and hyperkeratotic response relative to wild type. Together, our results show that epidermal loss of GR provokes skin barrier defects and cutaneous inflammation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/jid.2012.281

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sevilla, L. M., Latorre, V., Sanchis, A., & Pérez, P.
Affiliations
Consejo Superior de Investigaciones Científicas (ES)
Corresponding author
Pérez, Paloma
Venue
Journal of Investigative Dermatology
Publisher
Elsevier BV
Published
2013-02
Volume
133
Issue
2
Pages
361-370
ISSN
0022-202X (ISSN-L)
OpenAlex
W2006066882
Cited by
77
References
2
Citations by year
2026: 4 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 3 · 2021: 8 · 2020: 3 · 2019: 4 · 2018: 8 · 2017: 8 · 2016: 9 · 2015: 10 · 2014: 2 · 2013: 6 · 2012: 1
FWCI
7.62
Type
journal article
Language
en
Open access
Locations
  • Journal of Investigative Dermatology (publishedVersion)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, other-oa)
Funders
  • Generalitat Valenciana
  • European Commission
  • Ministerio de Ciencia e Innovación (ACOMP2011/127, BES-2009-021944)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
glucocorticoid receptor, keratinocytes, skin barrier formation, keratinocyte differentiation, keratinocyte proliferation, epidermal differentiation complex, S100A8/A9, thymic stromal lymphopoietin, atopic dermatitis, psoriasis, mast cell degranulation, macrophage infiltration, ERK activation, STAT3 phosphorylation, skin homeostasis, hyperkeratosis
MeSH terms
Epidermal Cells, Animals, Animals, Newborn, Cell Differentiation, Dermatitis, Epidermis, Female, Genetic Markers, Male, Pregnancy, Receptors, Glucocorticoid, Skin Tests, Keratinocytes, Up-Regulation, Mice, Knockout, MAP Kinase Signaling System, Cell Proliferation, STAT3 Transcription Factor, Proto-Oncogene Proteins c-akt, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review